Intellectual Property India Publishes Patent Application for '2-Hydroxypropyl-Beta-Cyclodextrin As A Cancer Therapy Neoadjuvant Or Adjuvant' Filed by University Of The Witwatersrand

MUMBAI, India, March 28 -- Intellectual Property India has published a patent application (202527013493 A) filed by University Of The Witwatersrand, Johannesburg, South Africa, on Feb. 17, for '2-hydroxypropyl-beta-cyclodextrin as a cancer therapy neoadjuvant or adjuvant.'

Inventor(s) include Kaur, Mandeep; Abdulla, Naaziyah; Aronson, Ruth; Perumal, Shanen; and Pillay, Ruvesh.

The application for the patent was published on March 28, under issue no. 13/2025.

According to the abstract released by the Intellectual Property India: "The invention relates to a compound, 2-hydroxypropyl--cyclodextrin (HPCD), for use in methods of treating cancer, as well as to methods of treating a cancer using the compound HPCD and to uses of the compound in ...